Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Uta Erdbruegger, MD, FAHA

Welcome to the Council on the Kidney in Cardiovascular Disease (KCVD). Our Council is committed to advancing the understanding of the complex interactions between the kidney and the cardiovascular system through scientific excellence, collaboration, education, and advocacy. As an integral part of the American Heart Association, we bring together basic, translational, clinical, and population scientists, as well as healthcare professionals, to accelerate discoveries that improve cardiovascular and kidney health.

Uta Erdbruegger, MD, FAHA
Chair, Council on the Kidney in Cardiovascular Disease

Your Work—and Your Colleagues’—Deserves Recognition

Explore 2026 Heart Association council award opportunities recognizing excellence at every career stage, with awards presented at our Meetings & Conferences.

View 2026 Council Awards

Join us for Hypertension 2026

October 7-11, 2026
Hyatt Regency Crystal City | Arlington, Virginia
black male doctor

American Heart Association Professional Members are Difference Makers

research

Current AHA Research Grant and Funding Opportunities

Grant and funding opportunities are posted throughout the year. Check out a complete listing of current RFPs and apply to fund your research today.

Hypertension Journal cover

Hypertension

Hypertension is one of 14 AHA scientific journals. It represents the Councils on Hypertension and KCVD.

American Heart Association PREVENT™ Calculator

Male doctor showing information on the digital tablet he is holding to a female patient.

The American Heart Association PREVENT™ equations are designed to estimate cardiovascular disease risk based on cardiovascular, kidney and metabolic health factors.

New! Member Benefit - Access Advisory & Consulting Opportunities - Get started with MDisrupt. The American Heart Association has made a financial investment in MDisrupt.

New! Member Benefit

Access Advisory & Consulting Opportunities

Get started with MDisrupt

The American Heart Association has made a financial investment in MDisrupt.

Four Days. Global Experts. Limitless Discovery.

Scientific Sessions 2026
November 6–9, 2026
Chicago, Illinois 

AHA26 is the global stage for breakthrough cardiovascular science, uniting experts, innovators, and future leader for four immersive days of discovery and collaboration.